Lv4
768 积分 2023-03-01 加入
Bulumtatug Fuvedotin (BFv, 9MW2821), a next-generation Nectin-4 targeting antibody–drug conjugate, in patients with advanced solid tumors: a first-in-human, open-label, multicenter, phase I/II study
1天前
待确认
Ifinatamab deruxtecan, a B7-H3-directed antibody–drug conjugate, in patients with advanced solid tumours (IDeate-PanTumor01): dose-escalation results from a phase 1/2 trial
2天前
已完结
Ifinatamab deruxtecan, a B7-H3-directed antibody–drug conjugate, in patients with advanced solid tumours (IDeate-PanTumor01): dose-escalation results from a phase 1/2 trial
2天前
已完结
Effector mechanisms of therapeutic antibodies against ErbB receptors
2天前
已完结
A strategy for the efficient construction of anti-PD1-based bispecific antibodies with desired IgG-like properties
5天前
已完结
Identification of MUC1 Proteolytic Cleavage Sites in Vivo
10天前
已完结
Analysis of therapeutic monoclonal antibodies by imaged capillary isoelectric focusing (icIEF)
10天前
已完结
The Role of CT Radiomics Analysis in Predicting Overall Survival Following initial Chemotherapy for Diffuse Large B-cell Lymphoma
14天前
已完结
Improving Intracellular Delivery of an Antibody–Drug Conjugate Targeting Carcinoembryonic Antigen Increases Efficacy at Clinically Relevant Doses In Vivo
16天前
已完结
Aberrant, ectopic expression of VEGF and VEGF receptors 1 and 2 in malignant colonic epithelial cells. Implications for these cells growth via an autocrine mechanism
16天前
已完结
皖公网安备34019202002308
